Exact Sciences Corp (NAS:EXAS)
$ 54.33 -0.39 (-0.71%) Market Cap: 10.06 Bil Enterprise Value: 11.87 Bil PE Ratio: 0 PB Ratio: 3.13 GF Score: 80/100

Exact Sciences Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 13, 2022 / 10:20PM GMT
Release Date Price: $37.28 (-9.58%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Welcome, everybody. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs. Thanks, everybody, for joining us today. I have the pleasure of welcoming Exact Sciences to the stage here. Kevin Conroy, the Chairman of the Board and Chief Executive Officer; and Everett Cunningham, Chief Commercial Officer. Kevin, Everett, thank you for joining us today.

Kevin T. Conroy
Exact Sciences Corporation - Chairman of The Board & CEO

Thanks, Matt.

Everett Cunningham

Thanks, Matt. Appreciate being here.

Questions & Answers

Matthew Carlisle Sykes;Kevin T. Conroy<
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Maybe we'll just start off and let you set stage for a little bit and kind of talk about some of the recent highlights so far this year and kind of what investors should be focused on as we enter the second half of '22?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot